International Stem Cell (OTCMKTS:ISCO) Stock Price Crosses Above Two Hundred Day Moving Average – Should You Sell?

International Stem Cell Corp. (OTCMKTS:ISCO)’s share price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.20 and traded as high as $0.3821. International Stem Cell shares last traded at $0.3821, with a volume of 11,863 shares changing hands.

International Stem Cell Stock Performance

The company has a 50 day moving average price of $0.28 and a 200 day moving average price of $0.20. The firm has a market cap of $3.06 million, a PE ratio of -4.78 and a beta of -0.01.

International Stem Cell (OTCMKTS:ISCO) last released its quarterly earnings results on Thursday, August 13th. The biotechnology company reported ($0.01) earnings per share for the quarter. The company had revenue of $2.67 million during the quarter.

International Stem Cell Company Profile

International Stem Cell Corporation (OTCMKTS:ISCO) is a biotechnology company focused on the development and commercialization of human parthenogenetic stem cells (hpSC) for therapeutic and research applications. Parthenogenetic stem cells are derived from unfertilized human eggs and offer a scalable, ethically noncontroversial source of pluripotent cells. ISCO’s proprietary hpSC lines can be directed to differentiate into a wide variety of cell types, enabling preclinical programs in areas such as neurodegenerative disease, liver disease, diabetes and corneal regeneration.

In addition to its therapeutic pipeline, International Stem Cell maintains a research products division that supplies hpSC lines, differentiated cell populations and media formulations to academic institutions, biotechnology companies and contract research organizations.